Black Diamond Therapeutics, Inc. (BDTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 79
-0.02
-1.105%
$
106.58M Market Cap
- P/E Ratio
- Div Yield
708,200 Volume
-1.71 Eps
$ 1.81
Previous Close 
Want to track BDTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Black Diamond Therapeutics, Inc. (BDTX) Statistics
Valuation metrics
Market Cap 106.58M
Enterprise value 90.38M
Trailing P/E (ttm) -2.36
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.98
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 627.24K
Average volume (90 days) 1.89M
Price summary
52-Week low 1.6
52-Week high 4.94
Beta -
50-Day moving average 1.8
200-Day moving average 2.49
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.33%
Return on equity -0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.07
Total debt (mrq) -
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 8.46%
Book value per share (mrq) 1.82
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
